These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
New York
|
|
81-2983623
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
|
100 Campus Drive, Suite 200E
Florham Park, New Jersey
|
|
07932
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Class
|
|
Outstanding at April 30, 2017
|
|
Common Stock, $0.01 par value
|
|
209,319,952
|
|
|
Page
|
|
|
|
||
|
Item 1.
|
|
|
|
|
Condensed Consolidated Statements of Income (Loss)
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income (Loss)
|
|
|
|
Condensed Consolidated Balance Sheets
|
|
|
|
Condensed Consolidated Statements of Cash Flows
|
|
|
|
Notes to the Condensed Consolidated Financial Statements
|
|
|
Item 2.
|
||
|
|
||
|
|
Market
Risk Management
|
|
|
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 6.
|
||
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions, except per-share data)
|
|
2017
|
|
2016
|
||||
|
Revenues
|
|
|
|
|
||||
|
Revenue
|
|
$
|
1,542
|
|
|
$
|
1,673
|
|
|
Related party
|
|
11
|
|
|
12
|
|
||
|
Total Revenues
|
|
$
|
1,553
|
|
|
$
|
1,685
|
|
|
Costs and Expenses
|
|
|
|
|
||||
|
Cost of services
|
|
$
|
1,287
|
|
|
$
|
1,412
|
|
|
Related party cost of services
|
|
7
|
|
|
9
|
|
||
|
Research and development
|
|
4
|
|
|
10
|
|
||
|
Selling, administrative and general
|
|
169
|
|
|
183
|
|
||
|
Restructuring and related costs
|
|
18
|
|
|
26
|
|
||
|
Amortization of intangible assets
|
|
61
|
|
|
75
|
|
||
|
Interest expense
|
|
36
|
|
|
1
|
|
||
|
Related party interest
|
|
—
|
|
|
10
|
|
||
|
Separation costs
|
|
5
|
|
|
3
|
|
||
|
Other (income) expenses, net
|
|
(12
|
)
|
|
10
|
|
||
|
Total Costs and Expenses
|
|
1,575
|
|
|
1,739
|
|
||
|
Loss before Income Taxes
|
|
(22
|
)
|
|
(54
|
)
|
||
|
Income tax benefit
|
|
(12
|
)
|
|
(31
|
)
|
||
|
Loss from Continuing Operations
|
|
(10
|
)
|
|
(23
|
)
|
||
|
Income from discontinued operations, net of tax
|
|
4
|
|
|
—
|
|
||
|
Net Loss
|
|
$
|
(6
|
)
|
|
$
|
(23
|
)
|
|
|
|
|
|
|
||||
|
Basic Earnings (Loss) per Share:
|
|
|
|
|
||||
|
Continuing operations
|
|
$
|
(0.06
|
)
|
|
$
|
(0.12
|
)
|
|
Discontinued operations
|
|
0.02
|
|
|
—
|
|
||
|
Total Basic Loss per Share
|
|
$
|
(0.04
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
|
|
|
||||
|
Diluted Earnings (Loss) per Share:
|
|
|
|
|
||||
|
Continuing operations
|
|
$
|
(0.06
|
)
|
|
$
|
(0.12
|
)
|
|
Discontinued operations
|
|
0.02
|
|
|
—
|
|
||
|
Total Diluted Loss per Share
|
|
$
|
(0.04
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
|
2017
|
|
2016
|
||||
|
Net Loss
|
|
$
|
(6
|
)
|
|
$
|
(23
|
)
|
|
|
|
|
|
|
||||
|
Other Comprehensive Income, Net
(1)
:
|
|
|
|
|
||||
|
Translation adjustments, net
|
|
12
|
|
|
7
|
|
||
|
Unrealized gains, net
|
|
2
|
|
|
2
|
|
||
|
Changes in defined benefit plans, net
|
|
1
|
|
|
—
|
|
||
|
Other Comprehensive Income, Net
|
|
15
|
|
|
9
|
|
||
|
|
|
|
|
|
||||
|
Comprehensive Income (Loss), Net
|
|
$
|
9
|
|
|
$
|
(14
|
)
|
|
(in millions, except share data in thousands)
|
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
Assets
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
255
|
|
|
$
|
390
|
|
|
Accounts receivable, net
|
|
1,408
|
|
|
1,286
|
|
||
|
Net receivable from former parent company
|
|
41
|
|
|
—
|
|
||
|
Other current assets
|
|
270
|
|
|
241
|
|
||
|
Total current assets
|
|
1,974
|
|
|
1,917
|
|
||
|
Land, buildings and equipment, net
|
|
282
|
|
|
283
|
|
||
|
Intangible assets, net
|
|
1,083
|
|
|
1,144
|
|
||
|
Goodwill
|
|
3,899
|
|
|
3,889
|
|
||
|
Other long-term assets
|
|
462
|
|
|
476
|
|
||
|
Total Assets
|
|
$
|
7,700
|
|
|
$
|
7,709
|
|
|
Liabilities and Equity
|
|
|
|
|
||||
|
Short-term debt and current portion of long-term debt
|
|
$
|
46
|
|
|
$
|
28
|
|
|
Accounts payable
|
|
130
|
|
|
164
|
|
||
|
Accrued compensation and benefits costs
|
|
257
|
|
|
269
|
|
||
|
Unearned income
|
|
212
|
|
|
206
|
|
||
|
Net payable to former parent company
|
|
—
|
|
|
124
|
|
||
|
Other current liabilities
|
|
603
|
|
|
611
|
|
||
|
Total current liabilities
|
|
1,248
|
|
|
1,402
|
|
||
|
Long-term debt
|
|
2,075
|
|
|
1,913
|
|
||
|
Pension and other benefit liabilities
|
|
172
|
|
|
172
|
|
||
|
Deferred taxes
|
|
616
|
|
|
619
|
|
||
|
Other long-term liabilities
|
|
148
|
|
|
173
|
|
||
|
Total Liabilities
|
|
4,259
|
|
|
4,279
|
|
||
|
|
|
|
|
|
||||
|
Contingencies (See Note 11)
|
|
|
|
|
|
|
||
|
Series A Convertible Preferred Stock
|
|
142
|
|
|
142
|
|
||
|
|
|
|
|
|
||||
|
Common Stock
|
|
2
|
|
|
2
|
|
||
|
Additional paid-in-capital
|
|
3,816
|
|
|
3,812
|
|
||
|
Retained deficit
|
|
(8
|
)
|
|
—
|
|
||
|
Accumulated other comprehensive loss
|
|
(511
|
)
|
|
(526
|
)
|
||
|
Total Equity
|
|
3,299
|
|
|
3,288
|
|
||
|
Total Liabilities and Equity
|
|
$
|
7,700
|
|
|
$
|
7,709
|
|
|
|
|
|
|
|
||||
|
Shares of common stock issued and outstanding
|
|
203,640
|
|
|
202,875
|
|
||
|
Shares of Series A convertible preferred stock issued and outstanding
|
|
120
|
|
|
120
|
|
||
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
|
2017
|
|
2016
|
||||
|
Cash Flows from Operating Activities:
|
|
|
|
|
||||
|
Net loss
|
|
$
|
(6
|
)
|
|
$
|
(23
|
)
|
|
Adjustments required to reconcile net loss to cash flows from operating activities:
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
125
|
|
|
148
|
|
||
|
Provision for receivables
|
|
—
|
|
|
2
|
|
||
|
Deferred tax (benefit) expense
|
|
(6
|
)
|
|
5
|
|
||
|
Gain on investments
|
|
(3
|
)
|
|
—
|
|
||
|
Amortization of debt financing costs
|
|
2
|
|
|
—
|
|
||
|
Net gain on sales of businesses and assets
|
|
(7
|
)
|
|
—
|
|
||
|
Stock-based compensation
|
|
6
|
|
|
4
|
|
||
|
Restructuring and related charges
|
|
12
|
|
|
25
|
|
||
|
Payments for restructuring
|
|
(9
|
)
|
|
(7
|
)
|
||
|
Contributions to defined benefit pension plans
|
|
(2
|
)
|
|
(2
|
)
|
||
|
Increase in accounts receivable
|
|
(110
|
)
|
|
(141
|
)
|
||
|
Increase in other current and long-term assets
|
|
(33
|
)
|
|
(26
|
)
|
||
|
Decrease in accounts payable and accrued compensation
|
|
(49
|
)
|
|
(66
|
)
|
||
|
Decrease in other current and long-term liabilities
|
|
(17
|
)
|
|
(11
|
)
|
||
|
Net change in income tax assets and liabilities
|
|
(9
|
)
|
|
(25
|
)
|
||
|
Net cash used in operating activities
|
|
(106
|
)
|
|
(117
|
)
|
||
|
Cash Flows from Investing Activities:
|
|
|
|
|
||||
|
Cost of additions to land, buildings and equipment
|
|
(17
|
)
|
|
(30
|
)
|
||
|
Cost of additions to internal use software
|
|
(8
|
)
|
|
(9
|
)
|
||
|
Proceeds from sale of businesses, net of adjustments
|
|
—
|
|
|
(56
|
)
|
||
|
Net payments on related party notes receivable
|
|
—
|
|
|
(3
|
)
|
||
|
Other investing
|
|
—
|
|
|
1
|
|
||
|
Net cash used in investing activities
|
|
(25
|
)
|
|
(97
|
)
|
||
|
Cash Flows from Financing Activities:
|
|
|
|
|
||||
|
Proceeds on long term debt, net of issuance costs
|
|
305
|
|
|
2
|
|
||
|
Payments on debt
|
|
(144
|
)
|
|
(6
|
)
|
||
|
Net proceeds on related party notes payable
|
|
—
|
|
|
9
|
|
||
|
Net (payments) to, transfers from former parent
|
|
(161
|
)
|
|
211
|
|
||
|
Proceeds from exercise of stock options
|
|
2
|
|
|
—
|
|
||
|
Dividends paid on preferred stock
|
|
(2
|
)
|
|
—
|
|
||
|
Other financing
|
|
(6
|
)
|
|
—
|
|
||
|
Net cash (used in) provided by financing activities
|
|
(6
|
)
|
|
216
|
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
2
|
|
|
1
|
|
||
|
(Decrease) increase in cash and cash equivalents
|
|
(135
|
)
|
|
3
|
|
||
|
Cash and cash equivalents at beginning of period
|
|
390
|
|
|
140
|
|
||
|
Cash and Cash Equivalents at End of Period
|
|
$
|
255
|
|
|
$
|
143
|
|
|
•
|
Accounting Changes and Error Corrections
:
(Topic 250):
ASU 2017-03
,
Accounting Changes and Error Corrections (Topic 250) and Investments-Equity Method and Joint Ventures (Topic 323)
. Transition guidance included in certain issued but not yet adopted ASUs was updated to reflect this amendment.
|
|
•
|
Financial Instruments
:
ASU 2016-01
,
Financial Instruments - Recognition and Measurement of Financial Instruments and Financial Liabilities,
which is effective for our fiscal year beginning January 1, 2018, and is not expected to have a material impact on our financial condition, results of operations or cash flows.
|
|
•
|
Inventory
:
ASU 2015-11
,
Simplifying the Subsequent Measurement of Inventory,
which is effective for our fiscal year beginning January 1, 2017, did not have a material impact on our financial condition, results of operations or cash flows.
|
|
•
|
Derivatives and Hedging
:
ASU 2016-06
,
Contingent Put and Call Options in Debt Instruments
, was effective for our fiscal year beginning January 1, 2017, and did not have a material impact on our financial condition, results of operations or cash flows.
|
|
•
|
Derivatives and Hedging
:
ASU 2016-05
,
Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships
, was effective for our fiscal year beginning January 1, 2017, and did not have a material impact on our financial condition, results of operations or cash flows.
|
|
•
|
Commercial Industries
|
|
•
|
Public Sector
|
|
•
|
Other
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
Segment
Revenue
|
|
Segment Profit (Loss)
|
||||
|
2017
|
|
|
|
|
||||
|
Commercial Industries
|
|
$
|
923
|
|
|
$
|
29
|
|
|
Public Sector
|
|
549
|
|
|
61
|
|
||
|
Other
|
|
81
|
|
|
(4
|
)
|
||
|
Total
|
|
$
|
1,553
|
|
|
$
|
86
|
|
|
2016
|
|
|
|
|
||||
|
Commercial Industries
|
|
$
|
1,007
|
|
|
$
|
26
|
|
|
Public Sector
|
|
571
|
|
|
61
|
|
||
|
Other
|
|
107
|
|
|
(16
|
)
|
||
|
Total
|
|
$
|
1,685
|
|
|
$
|
71
|
|
|
|
Three Months Ended
March 31, |
||||||
|
Reconciliation to Pre-tax Income (Loss)
|
2017
|
|
2016
|
||||
|
Segment Profit
|
$
|
86
|
|
|
$
|
71
|
|
|
Reconciling items:
|
|
|
|
||||
|
Amortization of intangible assets
|
(61
|
)
|
|
(75
|
)
|
||
|
Restructuring and related costs
|
(18
|
)
|
|
(26
|
)
|
||
|
Interest Expense
|
(36
|
)
|
|
(1
|
)
|
||
|
Related party interest
|
—
|
|
|
(10
|
)
|
||
|
Separation costs
(1)
|
(5
|
)
|
|
(3
|
)
|
||
|
Other income (expense), net
|
12
|
|
|
(10
|
)
|
||
|
Pre-tax Loss
|
$
|
(22
|
)
|
|
$
|
(54
|
)
|
|
(1)
|
Separation costs are expenses incurred in connection with the separation into an independent, publicly-traded companies. These costs are primarily for third-party investment banking, accounting, legal, consulting and other similar types of services related to the separation transaction as well as costs associated with the operational separation of the
two
companies, such as those related to human resources, brand management, real estate and information management to the extent not capitalized.
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Amounts billed or billable
|
|
$
|
1,142
|
|
|
$
|
1,014
|
|
|
Unbilled amounts
|
|
272
|
|
|
279
|
|
||
|
Allowance for doubtful accounts
|
|
(6
|
)
|
|
(7
|
)
|
||
|
Accounts Receivable, Net
|
|
$
|
1,408
|
|
|
$
|
1,286
|
|
|
•
|
$7
to discontinued operations as a portion of the receivable was related to a business that was part of our ITO discontinued operation; and
|
|
•
|
$7
to continuing operations as the remainder of the receivable was related to our continuing Healthcare Provider business; the majority of the
$7
is reflected in legal settlements in Other (income) expense, net.
|
|
|
Severance and
Related Costs
|
|
Lease Cancellation
and Other Costs
|
|
Asset Impairments
(2)
|
|
Total
|
||||||||
|
Balance at December 31, 2016
|
$
|
15
|
|
|
$
|
5
|
|
|
$
|
1
|
|
|
$
|
21
|
|
|
Restructuring provision
|
11
|
|
|
3
|
|
|
—
|
|
|
14
|
|
||||
|
Reversals of prior accruals
|
(1
|
)
|
|
(1
|
)
|
|
—
|
|
|
(2
|
)
|
||||
|
Net Current Period Charges
(1)
|
10
|
|
|
2
|
|
|
—
|
|
|
12
|
|
||||
|
Charges against reserve and currency
|
(8
|
)
|
|
(1
|
)
|
|
—
|
|
|
(9
|
)
|
||||
|
Balance at March 31, 2017
|
$
|
17
|
|
|
$
|
6
|
|
|
$
|
1
|
|
|
$
|
24
|
|
|
(1)
|
Represents net amount recognized within the Condensed Consolidated Statements of Income for the period shown.
|
|
(2)
|
Charges associated with asset impairments represent the write-down of the related assets to their new cost basis and are recorded concurrently with the recognition of the provision.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2017
|
|
2016
|
||||
|
Charges against reserve
|
$
|
9
|
|
|
$
|
7
|
|
|
Restructuring Cash Payments
|
$
|
9
|
|
|
$
|
7
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2017
|
|
2016
|
||||
|
Commercial Industries
|
$
|
8
|
|
|
$
|
21
|
|
|
Public Sector
|
3
|
|
|
1
|
|
||
|
Other
|
1
|
|
|
3
|
|
||
|
Total Net Restructuring Charges
|
$
|
12
|
|
|
$
|
25
|
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Revolving credit facility
|
|
$
|
70
|
|
|
$
|
—
|
|
|
Term loan A due 2021
(1)
|
|
699
|
|
|
694
|
|
||
|
Term loan B due 2023
|
|
848
|
|
|
750
|
|
||
|
Senior notes due 2024
|
|
510
|
|
|
510
|
|
||
|
Capital lease obligations
|
|
48
|
|
|
43
|
|
||
|
Principal Debt Balance
|
|
$
|
2,175
|
|
|
$
|
1,997
|
|
|
Debt issuance costs and unamortized discounts
|
|
(54
|
)
|
|
(56
|
)
|
||
|
Less: current maturities
|
|
(46
|
)
|
|
(28
|
)
|
||
|
Total Long-term Debt
|
|
$
|
2,075
|
|
|
$
|
1,913
|
|
|
(1)
|
The aggregate principal debt for Term Loan A includes borrowings in both U.S Dollars and Euros.
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Assets:
|
|
|
|
||||
|
Foreign exchange contracts - forwards
|
$
|
2
|
|
|
$
|
1
|
|
|
Deferred compensation investments in cash surrender life insurance
|
102
|
|
|
99
|
|
||
|
Deferred compensation investments in mutual funds
|
9
|
|
|
10
|
|
||
|
Total
|
$
|
113
|
|
|
$
|
110
|
|
|
Liabilities:
|
|
|
|
||||
|
Foreign exchange contracts - forwards
|
$
|
1
|
|
|
$
|
3
|
|
|
Deferred compensation plan liabilities
|
117
|
|
|
113
|
|
||
|
Total
|
$
|
118
|
|
|
$
|
116
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
Carrying
Amount
|
|
Fair
Value
|
|
Carrying
Amount
|
|
Fair
Value
|
||||||||
|
Cash and cash equivalents
|
$
|
255
|
|
|
$
|
255
|
|
|
$
|
390
|
|
|
$
|
390
|
|
|
Restricted cash - related party
|
18
|
|
|
18
|
|
|
18
|
|
|
18
|
|
||||
|
Accounts receivable, net
|
1,408
|
|
|
1,408
|
|
|
1,286
|
|
|
1,286
|
|
||||
|
Short-term debt
|
46
|
|
|
46
|
|
|
28
|
|
|
28
|
|
||||
|
Long-term debt
|
2,075
|
|
|
2,158
|
|
|
1,913
|
|
|
1,933
|
|
||||
|
|
Three Months Ended March 31,
|
||||||||||||||
|
|
Pension Benefits
|
||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||||||
|
Components of Net Periodic Benefit Costs:
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Service cost
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
1
|
|
|
Interest cost
|
1
|
|
|
1
|
|
|
1
|
|
|
1
|
|
||||
|
Expected return on plan assets
|
(1
|
)
|
|
(1
|
)
|
|
(2
|
)
|
|
(2
|
)
|
||||
|
Defined Benefit Plans
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Defined contribution plans
|
8
|
|
|
7
|
|
|
2
|
|
|
1
|
|
||||
|
Net Periodic Benefit Cost
|
8
|
|
|
7
|
|
|
2
|
|
|
1
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Other changes in plan assets and benefit obligations recognized in Other Comprehensive Loss:
|
|
|
|
|
|
|
|
||||||||
|
Net actuarial gain
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
||||
|
Total Recognized in Other Comprehensive Loss
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
||||
|
Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Loss
|
$
|
8
|
|
|
$
|
7
|
|
|
$
|
1
|
|
|
$
|
1
|
|
|
|
|
Three Months Ended March 31,
|
||||||||||||||
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
|
Pre-tax
|
|
Net of Tax
|
|
Pre-tax
|
|
Net of Tax
|
||||||||
|
Translation Adjustments Gains
|
|
$
|
12
|
|
|
$
|
12
|
|
|
$
|
7
|
|
|
$
|
7
|
|
|
Unrealized Gains:
|
|
|
|
|
|
|
|
|
||||||||
|
Changes in fair value of cash flow hedges - gains
|
|
2
|
|
|
2
|
|
|
2
|
|
|
1
|
|
||||
|
Changes in cash flow hedges reclassified to earnings
(1)
|
|
1
|
|
|
—
|
|
|
1
|
|
|
1
|
|
||||
|
Net Unrealized Gains
|
|
3
|
|
|
2
|
|
|
3
|
|
|
2
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Defined Benefit Plans Gains:
|
|
|
|
|
|
|
|
|
||||||||
|
Net actuarial gains
(2)
|
|
1
|
|
|
1
|
|
|
—
|
|
|
—
|
|
||||
|
Changes in Defined Benefit Plans Gains
|
|
1
|
|
|
1
|
|
|
—
|
|
|
—
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other Comprehensive Income
|
|
$
|
16
|
|
|
$
|
15
|
|
|
$
|
10
|
|
|
$
|
9
|
|
|
(1)
|
Reclassified to Cost of outsourcing. Refer to Note 7 - Financial Instruments for additional information regarding our cash flow hedges.
|
|
(2)
|
Reclassified to Total Net Periodic Benefit Cost. Refer to Note 9 - Employee Benefit Plans for additional information.
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Cumulative translation adjustments
|
|
$
|
(460
|
)
|
|
$
|
(472
|
)
|
|
Other unrealized losses, net
|
|
1
|
|
|
(1
|
)
|
||
|
Benefit plans net actuarial losses and prior service credits
|
|
(52
|
)
|
|
(53
|
)
|
||
|
Total Accumulated Other Comprehensive Loss
|
|
$
|
(511
|
)
|
|
$
|
(526
|
)
|
|
|
Common
Stock
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
AOCL
(1)
|
|
Former Parent Company Investment
|
|
Conduent Shareholders'
Equity
|
||||||||||||
|
Balance at December 31, 2016
|
$
|
2
|
|
|
$
|
3,812
|
|
|
$
|
—
|
|
|
$
|
(526
|
)
|
|
$
|
—
|
|
|
$
|
3,288
|
|
|
Comprehensive income, net
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
15
|
|
|
—
|
|
|
9
|
|
||||||
|
Cash dividends paid - preferred stock
(2)
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
||||||
|
Stock option and incentive plans, net
|
—
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4
|
|
||||||
|
Balance at March 31, 2017
|
$
|
2
|
|
|
$
|
3,816
|
|
|
$
|
(8
|
)
|
|
$
|
(511
|
)
|
|
$
|
—
|
|
|
$
|
3,299
|
|
|
|
Common
Stock
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
AOCL
(1)
|
|
Former Parent Company Investment
|
|
Conduent Shareholders'
Equity
|
||||||||||||
|
Balance at December 31, 2015
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(181
|
)
|
|
$
|
5,343
|
|
|
$
|
5,162
|
|
|
Comprehensive income (loss),net
|
—
|
|
|
—
|
|
|
—
|
|
|
9
|
|
|
(23
|
)
|
|
(14
|
)
|
||||||
|
Net transfers from former parent
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
241
|
|
|
241
|
|
||||||
|
Balance at March 31, 2016
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(172
|
)
|
|
$
|
5,561
|
|
|
$
|
5,389
|
|
|
(1)
|
AOCL - Accumulated other comprehensive loss.
|
|
(2)
|
Cash dividends on preferred stock of
$20.00
per share for the first quarter of 2017.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2017
|
|
2016
|
||||
|
Basic Earnings (Loss) per Share:
|
|
|
|
||||
|
Net loss from continuing operations
|
$
|
(10
|
)
|
|
$
|
(23
|
)
|
|
Accrued dividends on preferred stock
|
(2
|
)
|
|
—
|
|
||
|
Adjusted Net Loss From Continuing Operations Available to Common Shareholders
|
(12
|
)
|
|
(23
|
)
|
||
|
Income from discontinued operations, net of tax
|
4
|
|
|
—
|
|
||
|
Adjusted Net Loss Available to Common Shareholders
|
$
|
(8
|
)
|
|
$
|
(23
|
)
|
|
Weighted average common shares outstanding
|
203,400
|
|
|
202,875
|
|
||
|
|
|
|
|
||||
|
Basic Earnings (Loss) per Share:
|
|
|
|
||||
|
Continuing operations
|
$
|
(0.06
|
)
|
|
$
|
(0.12
|
)
|
|
Discontinued operations
|
0.02
|
|
|
—
|
|
||
|
Basic Loss per Share
|
$
|
(0.04
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
|
|
||||
|
Diluted Earnings (Loss) per Share:
|
|
|
|
||||
|
Net loss from continuing operations
|
$
|
(10
|
)
|
|
$
|
(23
|
)
|
|
Accrued dividends on preferred stock
|
(2
|
)
|
|
—
|
|
||
|
Adjusted net loss from continuing operations available to common shareholders
|
(12
|
)
|
|
(23
|
)
|
||
|
Net income from discontinued operations
|
4
|
|
|
—
|
|
||
|
Adjusted Net Loss Available to Common Shareholders
|
$
|
(8
|
)
|
|
$
|
(23
|
)
|
|
Weighted average common shares outstanding
|
203,400
|
|
|
202,875
|
|
||
|
|
|
|
|
||||
|
Diluted Earnings (Loss) per Share:
|
|
|
|
||||
|
Continuing operations
|
$
|
(0.06
|
)
|
|
$
|
(0.12
|
)
|
|
Discontinued operations
|
0.02
|
|
|
—
|
|
||
|
Diluted Loss per Share:
|
$
|
(0.04
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
|
|
||||
|
The following securities were not included in the computation of diluted earnings per share as they were either contingently issuable shares or shares that if included would have been anti-dilutive:
|
|||||||
|
Stock options
|
665
|
|
|
—
|
|
||
|
Restricted stock and performance shares
|
4,916
|
|
|
—
|
|
||
|
Convertible preferred stock
|
5,393
|
|
|
—
|
|
||
|
Total Anti-Dilutive Securities
|
10,974
|
|
|
—
|
|
||
|
|
|
Three Months Ended
March 31, |
|
|
|
|
||||||||
|
(in millions)
|
|
2017
|
|
2016
|
|
% Change
|
|
CC % Change
|
||||||
|
Total Revenues
|
|
$
|
1,553
|
|
|
$
|
1,685
|
|
|
(8
|
)%
|
|
(7
|
)%
|
|
|
|
Reported
|
|
Adjusted
|
||||||||||||||||
|
|
|
Three Months Ended March 31,
|
|
Three Months Ended March 31,
|
||||||||||||||||
|
|
|
2017
|
|
2016
|
|
B/(W)
|
|
2017
|
|
2016
|
|
B/(W)
|
||||||||
|
Total Gross Margin
(1)
|
|
16.7
|
%
|
|
15.7
|
%
|
|
1.0
|
%
|
pts.
|
|
16.9
|
%
|
|
15.7
|
%
|
|
1.2
|
%
|
pts.
|
|
SAG as a % of Revenue
|
|
10.9
|
%
|
|
10.9
|
%
|
|
—
|
%
|
pts.
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
|
Pre-tax Income Margin
|
|
(1.4
|
)%
|
|
(3.2
|
)%
|
|
1.8
|
%
|
pts.
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
|
Operating Margin
(2)
|
|
5.5
|
%
|
|
4.2
|
%
|
|
1.3
|
%
|
pts.
|
|
5.7
|
%
|
|
4.2
|
%
|
|
1.5
|
%
|
pts.
|
|
(1)
|
Refer to the Gross Margin Reconciliation table in the "Non-GAAP Financial Measures" section.
|
|
(2)
|
Refer to the Operating Income/Margin reconciliation table in the "Non-GAAP Financial Measures" section.
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
2017
|
|
2016
|
||||
|
Currency losses (gains), net
|
$
|
2
|
|
|
$
|
(1
|
)
|
|
Litigation matters
|
1
|
|
|
6
|
|
||
|
Deferred compensation investment gains
|
(4
|
)
|
|
—
|
|
||
|
All other (income) expenses, net
|
(11
|
)
|
|
5
|
|
||
|
Total Other (Income) Expenses, Net
|
$
|
(12
|
)
|
|
$
|
10
|
|
|
(1)
|
Refer to the Effective Tax Rate reconciliation table in the "Non-GAAP Financial Measures" section.
|
|
(1)
|
Refer to the "Non-GAAP Financial Measures" section for a reconciliation of reported net income from continuing operations to adjusted net income.
|
|
•
|
Commercial Industries,
|
|
•
|
Public Sector, and
|
|
•
|
Other.
|
|
|
|
Three Months Ended March 31,
|
||||||||||||
|
(in millions)
|
|
Revenue
|
|
% of Total
Revenue |
|
Segment
Profit (Loss) |
|
Segment
Margin |
||||||
|
2017
|
|
|
|
|
|
|
|
|
||||||
|
Commercial Industries
|
|
$
|
923
|
|
|
59
|
%
|
|
$
|
29
|
|
|
3.1
|
%
|
|
Public Sector
|
|
549
|
|
|
36
|
%
|
|
61
|
|
|
11.1
|
%
|
||
|
Other
|
|
81
|
|
|
5
|
%
|
|
(4
|
)
|
|
(4.9
|
)%
|
||
|
Total
|
|
$
|
1,553
|
|
|
100
|
%
|
|
$
|
86
|
|
|
5.5
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||
|
2017 Adjusted:
(1)
|
|
|
|
|
|
|
|
|
||||||
|
Other
|
|
$
|
81
|
|
|
5
|
%
|
|
$
|
(1
|
)
|
|
(1.2
|
)%
|
|
Total
|
|
$
|
1,553
|
|
|
100
|
%
|
|
$
|
89
|
|
|
5.7
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||
|
2016
|
|
|
|
|
|
|
|
|
||||||
|
Commercial Industries
|
|
$
|
1,007
|
|
|
60
|
%
|
|
$
|
26
|
|
|
2.6
|
%
|
|
Public Sector
|
|
571
|
|
|
34
|
%
|
|
61
|
|
|
10.7
|
%
|
||
|
Other
|
|
107
|
|
|
6
|
%
|
|
(16
|
)
|
|
(15.0
|
)%
|
||
|
Total
|
|
$
|
1,685
|
|
|
100
|
%
|
|
$
|
71
|
|
|
4.2
|
%
|
|
(1)
|
Refer to the Other segment margin reconciliation table in the "Non-GAAP Financial Measures" section.
|
|
(1)
|
Refer to the Other segment margin reconciliation table in the "Non-GAAP Financial Measures" section.
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions)
|
|
2017
|
|
2016
|
||||
|
New business TCV
|
|
$
|
530
|
|
|
$
|
643
|
|
|
Renewals TCV
|
|
401
|
|
|
845
|
|
||
|
Total Signings
|
|
$
|
931
|
|
|
$
|
1,488
|
|
|
|
|
|
|
|
||||
|
Annual recurring revenue signings
|
|
$
|
143
|
|
|
$
|
129
|
|
|
Non-recurring revenue signings
|
|
$
|
92
|
|
|
$
|
83
|
|
|
|
Three Months Ended
March 31, |
|
|
||||||||
|
(in millions)
|
2017
|
|
2016
|
|
Change
|
||||||
|
Net cash used in operating activities
|
$
|
(106
|
)
|
|
$
|
(117
|
)
|
|
$
|
11
|
|
|
Net cash used in investing activities
|
(25
|
)
|
|
(97
|
)
|
|
72
|
|
|||
|
Net cash (used in) provided by financing activities
|
(6
|
)
|
|
216
|
|
|
(222
|
)
|
|||
|
Effect of exchange rate changes on cash and cash equivalents
|
2
|
|
|
1
|
|
|
1
|
|
|||
|
(Decrease) increase in cash and cash equivalents
|
(135
|
)
|
|
3
|
|
|
(138
|
)
|
|||
|
Cash and cash equivalents at beginning of period
|
390
|
|
|
140
|
|
|
250
|
|
|||
|
Cash and Cash Equivalents at End of Period
|
$
|
255
|
|
|
$
|
143
|
|
|
$
|
112
|
|
|
•
|
$31 million increase in accounts receivable due to timing of billings and collections
.
|
|
•
|
$17 million increase in accounts payable and accrued compensation due to timing of payments.
|
|
•
|
$15 million decrease due to higher net income tax payments in the current year compared to net income tax refunds in the prior year.
|
|
•
|
$7 million decrease related to other current and long-term assets.
|
|
•
|
$5 million decrease due to payments for separation-related costs.
|
|
•
|
$1 million decrease in pre-tax income before depreciation and amortization, loss on sales of business, HE charge adjustment, NY MMIS adjustment, separation-related costs and restructuring and related charges.
|
|
•
|
$2 million decrease reflecting wind-down payments associated with implementations in California, Montana and New York.
|
|
•
|
$2 million decrease in restructuring payments
.
|
|
•
|
$56 million decrease due to payments made in 2016 to Atos for final post-closing adjustments associated with the 2015 ITO divestiture.
|
|
•
|
$14 million decrease due to a decrease in capital expenditures (including internal use software) in 2017.
|
|
•
|
$372 million decrease due to net transfers to former parent.
|
|
•
|
$9 million decrease due to net payments to former parent on related party notes payable in 2016.
|
|
•
|
$169 million increase in proceeds on debt related to the additional Term Loan B borrowing of $100 million and net borrowings under the revolving credit facility.
|
|
•
|
Amortization of intangible assets. The amortization of intangible assets is driven by acquisition activity, which can vary in size, nature and timing as compared to other companies within our industry from period to period.
|
|
•
|
Restructuring and related costs. Restructuring and related costs include restructuring and asset impairment charges as well as costs associated with our Strategic Transformation program.
|
|
•
|
Separation costs. Separation costs are expenses incurred in connection with the separation from Xerox Corporation into a separate, independent, publicly traded company. These costs primarily relate to third-party investment banking, accounting, legal, consulting and other similar types of services related to the separation transaction as well as costs associated with the operational separation of the two companies.
|
|
•
|
Other (income) expenses net. Other (income) expenses, net includes losses (gains) on sales of business and assets, currency (gains) losses, net, litigation matters and all other (income) expenses, net.
|
|
•
|
NY MMIS (2017 only). Costs associated with the company not fully completing the State of New York Health enterprise platform project.
|
|
•
|
HE charge (2017 only). Costs associated with not fully completing the Health Enterprise Medical platform implementation projects in California and Montana.
|
|
•
|
Amortization of intangible assets. The amortization of intangible assets is driven by acquisition activity, which can vary in size, nature and timing as compared to other companies within our industry from period to period.
|
|
•
|
Restructuring and related costs. Restructuring and related costs include restructuring and asset impairment charges as well as costs associated with our Strategic Transformation program.
|
|
•
|
Separation costs. Separation costs are expenses incurred in connection with the separation from Xerox Corporation into a separate, independent, publicly traded company. These costs primarily relate to third-party investment banking, accounting, legal, consulting and other similar types of services related to the separation transaction as well as costs associated with the operational separation of the two companies.
|
|
•
|
Interest.
|
|
•
|
Other (income) expenses, net. Other (income) expenses, net includes losses (gains) on sales of business and assets, currency (gains) losses, net litigation matters and all other (income) expenses, net.
|
|
•
|
NY MMIS (2017 only). Costs associated with the company not fully completing the State of New York Health enterprise platform project.
|
|
•
|
HE charge (2017 only). Costs associated with not fully completing the Health Enterprise Medical platform implementation projects in California and Montana.
|
|
|
|
Three Months Ended
March 31, 2017 |
|
Three Months Ended
March 31, 2016 |
||||||||||||
|
(in millions, except earnings per share)
|
|
Net Income (Loss)
|
|
EPS
|
|
Net Income (Loss)
|
|
EPS
|
||||||||
|
Reported from continuing operations
|
|
$
|
(10
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(23
|
)
|
|
$
|
(0.12
|
)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
||||||||
|
Amortization of intangible assets
|
|
61
|
|
|
|
|
75
|
|
|
|
||||||
|
NY MMIS
|
|
8
|
|
|
|
|
—
|
|
|
|
||||||
|
Restructuring and related costs
|
|
18
|
|
|
|
|
26
|
|
|
|
||||||
|
HE charge
|
|
(5
|
)
|
|
|
|
—
|
|
|
|
||||||
|
Separation costs
|
|
5
|
|
|
|
|
3
|
|
|
|
||||||
|
Other (income) expenses, net
|
|
(12
|
)
|
|
|
|
10
|
|
|
|
||||||
|
Less: Income tax adjustments
(1)
|
|
(30
|
)
|
|
|
|
(44
|
)
|
|
|
||||||
|
Adjusted
|
|
$
|
35
|
|
|
$
|
0.16
|
|
|
$
|
47
|
|
|
$
|
0.22
|
|
|
(1)
|
Reflects the income tax (expense) benefit of the adjustments. Refer to Effective Tax Rate reconciliation below for details.
|
|
|
Three Months Ended
March 31, 2017 |
|
Three Months Ended
March 31, 2016 |
||||||||||||||||||
|
(in millions)
|
Pre-Tax Income (Loss)
|
|
Income Tax Expense (Benefit)
(2)
|
|
Effective
Tax Rate |
|
Pre-Tax Income (Loss)
|
|
Income Tax Expense (Benefit)
(2)
|
|
Effective
Tax Rate |
||||||||||
|
Reported from continuing operations
|
$
|
(22
|
)
|
|
$
|
(12
|
)
|
|
54.5
|
%
|
|
$
|
(54
|
)
|
|
$
|
(31
|
)
|
|
57.4
|
%
|
|
Non-GAAP Adjustments
(1)
|
75
|
|
|
30
|
|
|
|
|
114
|
|
|
44
|
|
|
|
||||||
|
Adjusted
|
$
|
53
|
|
|
$
|
18
|
|
|
34.0
|
%
|
|
$
|
60
|
|
|
$
|
13
|
|
|
21.7
|
%
|
|
(1)
|
Refer to Net Income (Loss) reconciliation for details.
|
|
(2)
|
The tax impact of Adjusted Pre-Tax Income (Loss) from continuing operations is calculated under the same accounting principles applied to the As Reported Pre-Tax Income under ASC 740, which employs an annual effective tax rate method to the results.
|
|
|
Three Months Ended
March 31, 2017 |
|
|
Reported from continuing operations
|
16.7
|
%
|
|
Adjustment:
|
|
|
|
NY MMIS
|
0.5
|
%
|
|
HE charge
|
(0.3
|
)%
|
|
Adjusted
|
16.9
|
%
|
|
|
Three Months Ended
March 31, 2017 |
|
|
|
Three Months Ended
March 31, 2016 |
|
|
||||||||||||||
|
(in millions)
|
Profit (Loss)
|
|
Revenue
|
|
Margin
|
|
Profit (Loss)
|
|
Revenue
|
|
Margin
|
||||||||||
|
Reported Pre-tax Loss
(1)
|
$
|
(22
|
)
|
|
$
|
1,553
|
|
|
(1.4
|
)%
|
|
$
|
(54
|
)
|
|
1,685
|
|
|
(3.2
|
)%
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Amortization of intangible assets
|
61
|
|
|
|
|
|
|
75
|
|
|
|
|
|
||||||||
|
NY MMIS
|
8
|
|
|
|
|
|
|
—
|
|
|
|
|
|
||||||||
|
Restructuring and related costs
|
18
|
|
|
|
|
|
|
26
|
|
|
|
|
|
||||||||
|
HE charge
|
(5
|
)
|
|
|
|
|
|
—
|
|
|
|
|
|
||||||||
|
Separation costs
|
5
|
|
|
|
|
|
|
3
|
|
|
|
|
|
||||||||
|
Interest
(2)
|
36
|
|
|
|
|
|
|
11
|
|
|
|
|
|
||||||||
|
Other (income) expenses, net
|
(12
|
)
|
|
|
|
|
|
10
|
|
|
|
|
|
||||||||
|
Adjusted Operating Income/Margin
|
$
|
89
|
|
|
$
|
1,553
|
|
|
5.7
|
%
|
|
$
|
71
|
|
|
$
|
1,685
|
|
|
4.2
|
%
|
|
(1)
|
Pre-Tax Loss and Revenue from continuing operations.
|
|
(2)
|
Includes related party interest of $0 million and $10 million in the three months ended March 31, 2017 and 2016, respectively.
|
|
|
|
Three Months Ended
March 31, 2017 |
|
|
|||||||
|
|
|
Revenue
|
|
Loss
|
|
Margin
|
|||||
|
Reported from continuing operations
|
|
$
|
81
|
|
|
$
|
(4
|
)
|
|
(4.9
|
)%
|
|
Adjustments:
|
|
|
|
|
|
|
|||||
|
NY MMIS
|
|
—
|
|
|
8
|
|
|
|
|||
|
HE charge
|
|
—
|
|
|
(5
|
)
|
|
|
|||
|
Adjusted Operating Margin
|
|
$
|
81
|
|
|
$
|
(1
|
)
|
|
(1.2
|
)%
|
|
(a)
|
Sales of Unregistered Securities during the Quarter ended
March 31, 2017
|
|
(b)
|
Issuer Purchases of Equity Securities during the Quarter ended
March 31, 2017
|
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum That May Be Purchased under the Plans or Programs
|
|||
|
January 1 through 31
|
—
|
|
|
$
|
—
|
|
|
n/a
|
|
n/a
|
|
February 1 through 28
|
—
|
|
|
—
|
|
|
n/a
|
|
n/a
|
|
|
March 1 through 31
|
—
|
|
|
—
|
|
|
n/a
|
|
n/a
|
|
|
Total
|
—
|
|
|
|
|
|
|
|
||
|
3.1
|
|
Restated Certificate of Incorporation of Registrant filed with the Department of the State of New York on December 31, 2016.
|
|
|
|
Incorporated by reference to Exhibit 3.1 to Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
|
|
|
|
|
|
3.2
|
|
Amended and Restated By-Laws of Registrant as amended through December 31, 2016.
|
|
|
|
Incorporated by reference to Exhibit 3.2 to Registrants Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
|
|
|
|
|
|
10.1(c)
|
|
Amendment No.1 to Credit Agreement, dated as of April 7, 2017, among Conduent Incorporated, Conduent Business Services, LLC, Affiliated Computer Services International B.V. and Conduent Finance, Inc., the Lenders from time to time party thereto and JPMorgan Chase Bank, N/A., as Administrative Agent.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed April 11, 2017.
|
|
|
|
|
|
10.6(a)(ii)
|
|
Form of Agreement under PIP.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed March 29, 2017.
|
|
|
|
|
|
10.6(a)(iii)
|
|
Form of Agreement under ELTIP.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed March 29, 2017.
|
|
|
|
|
|
10.6(a)(iv)
|
|
Form of Agreement under SIG.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed March 29, 2017.
|
|
|
|
|
|
31(a)
|
|
Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
|
|
31(b)
|
|
Certification of CFO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
|
|
32
|
|
Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase.
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase.
|
|
101.INS
|
|
XBRL Instance Document.
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase.
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase.
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Linkbase.
|
|
CONDUENT INCORPORATED
(Registrant)
|
|
|
|
|
|
By:
|
/
S
/ JAY T. CHU
|
|
|
Jay T. Chu
Vice President and
Chief Accounting Officer
(Principal Accounting Officer)
|
|
3.1
|
|
Restated Certificate of Incorporation of Registrant filed with the Department of the State of New York on December 31, 2016.
|
|
|
|
Incorporated by reference to Exhibit 3.1 to Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
|
|
|
|
|
|
3.2
|
|
Amended and Restated By-Laws of Registrant as amended through December 31, 2016.
|
|
|
|
Incorporated by reference to Exhibit 3.2 to Registrants Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
|
|
|
|
|
|
10.1(c)
|
|
Amendment No.1 to Credit Agreement, dated as of April 7, 2017, among Conduent Incorporated, Conduent Business Services, LLC, Affiliated Computer Services International B.V. and Conduent Finance, Inc., the Lenders from time to time party thereto and JPMorgan Chase Bank, N/A., as Administrative Agent.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed April 11, 2017.
|
|
|
|
|
|
10.6(a)(ii)
|
|
Form of Agreement under PIP.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed March 29, 2017.
|
|
|
|
|
|
10.6(a)(iii)
|
|
Form of Agreement under ELTIP.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed March 29, 2017.
|
|
|
|
|
|
10.6(a)(iv)
|
|
Form of Agreement under SIG.
|
|
|
|
Incorporated by reference to Registrant's Current Report on Form 8-K, filed March 29, 2017.
|
|
|
|
|
|
31(a)
|
|
Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
|
|
31(b)
|
|
Certification of CFO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
|
|
32
|
|
Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase.
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase.
|
|
101.INS
|
|
XBRL Instance Document.
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase.
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase.
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Linkbase.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|